Industry Sessions

Friday, September 18, 2015

13:00 – 14:30 

Auditorium I​

CERVICAL CANCER PREVENTION: IMPLEMENTING HPV PRIMARY SCREENING WITH TRIAGE INTO PRACTICE

Symposium Organized by: ROCHE

Chair: Mark Stoler, USA

13:15     WELCOME AND INTRODUCTION

Mark Stoler, USA

 13:20     CONSIDERATIONS ON CLINICAL VALIDATION OF HPV-BASED PRIMARY SCREENING

Mark Stoler, USA

13:30     TRIAGE STRATEGIES OF HPV+ WOMEN

Thomas Wright,

13:45     REAL-WORLD PRIMARY SCREENING STRATEGIES & LONG-TERM SAFETY: PERSPECTIVE FROM GERMANY

Ullrich Petry, Germany

14:03       REAL-WORLD PRIMARY SCREENING STRATEGIES & LONG-TERM SAFETY: PERSPECTIVE FROM SWEDEN

Kristina Elfgren, Sweden

14:21     Q & A

 

Saturday, September 19, 2015

7:30 – 8:30

Auditorium I

CLINICAL VALIDATION OF XPERT® HPV FOR USE IN PRIMARY CERVICAL CANCER

Symposium Organized by: CEPHEID

Chair: Scott Campbell, USA

07:30     OVERVIEW OF XPERT HPV DESIGN AND PERFORMANCE

Scott Campbell, USA

07:40     EVALUATING THE CLINICAL PERFORMANCE OF THE XPERT HPV ASSAY USING THE VALGENT FRAMEWORK

Kate Cuschieri, Scotland

08:00     VALIDATION OF INTRA-LAB REPRODUCIBILITY AND INTER-LAB AGREEMENT OF XPERT HPV ACCORDING TO INTERNATIONAL GUIDELINES

Davy Vanden Broeck, Belgium

08:20     Questions​

Saturday, September 19, 2015

13:00 -14:30

Auditorium I

ADDRESSING AND PREVENTING HPV-ASSOCIATED DISEASE: A GLOBAL HEALTH PRIORITY

Symposium Organized by: MEDSCAPE EDUCATION

CHAIR: Suzanne Garland, Australia

13:00  WELCOME AND INTRODUCTION

Suzanne Garland, Australia

13:10  THE DANISH CHILDHOOD VACCINATION PROGRAM                         

Susanne Krüger Kjær, Denmark

13:25  THE AUSTRALIAN HPV VACCINATION PROGRAMME          

Andrew Grulich, Australia

13:40  THE SCOTTISH NATIONAL HPV IMMUNISATION PROGRAMME        

Kevin Pollock, Scotland

13:55  BARRIERS AND OPPORTUNITIES

Suzanne Garland, Australia

14:05  QUESTION-AND-ANSWER SESSION                                                  

Suzanne Garland, Australia

14:20  CLOSING REMARKS

Suzanne Garland, Australia

To pre-register for the symposium please click here

SATURDAY, SEPTEMBER 19, 2015

16:40 -18:10​

Auditorium I

APTIMA HPV: THE NEED FOR DETECTING HPV MRNA FROM A CLINICAL AND COST PERSPECTIVE

Symposium Organized by: HOLOGIC​

16:4​0  CLINICAL PERFORMANCE OF THE APTIMA HPV TEST IN CERVICAL CANCER SCREENING​

Thomas Iftner, Germany

17:00  WEIGHING THE CLINICAL HARMS AND BENEFITS OF CERVICAL CANCER SCREENING                                             

Michael Randell, USA

17:30  EVALUATING COST EFFECTIVENESS OF DNA AND MRNA BASED CERVICAL CANCER SCREENING STRATEGIES

Juan Felix, USA


SUNDAY, SEPTEMBER 20, 2015​

13:00 – 14:30

Auditorium I

Cervarix®: PROTECTION BEYOND VACCINE TYPES – THE TOUGH QUESTIONS

Symposium Organized by: GSK

CHAIR: William Hausdorff ,USA

PROTECTION BEYOND VACCINE TYPES PROVIDED BY OTHER VACCINES: FACTS & DATA

William Hausdorff ,USA

MECHANISMS OF PROTECTION BEYOND VACCINE TYPES – CLUES FROM MODERN IMMUNOLOGY

Alberta Di Pasquale ,HUNGARY

PROTECTION BEYOND VACCINE TYPES WITH CERVARIX®– THE TOUGH QUESTIONS

Attila Mihalyi ,ITALY and William Hausdorff ,USA

 





BOOK YOUR HOTEL

Find the best deals

Keep Me Updated